Medisights Pioneers New Standard: AI Agents Capture Unprecedented Near Real-Time Market Intelligence in Complex Diseases Like Multiple Myeloma

Summary

Medisights announced completion of a landmark study demonstrating AI agents' ability to provide near real-time market intelligence in complex diseases like multiple myeloma. The announcement highlights the company's AI-native platform capabilities for life sciences applications.